Cell-mediated autophagy promotes cancer cell survival

Cancer Research

Volumn 72, Issue 12, 2012, Pages 2970-2979

  Buchser, William J ^a   Laskow, Thomas C ^a   Pavlik, Philip J ^a   Lin, Hui Min ^b   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2; PROTEIN P62; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ARTICLE; AUTOPHAGY; CANCER CELL; CELL CONTACT; CELL FUNCTION; CELL INTERACTION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LYMPHOCYTE; LYMPHOID CELL; NATURAL KILLER CELL; PANCREAS CANCER; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TARGET CELL; TREATMENT RESPONSE; TUMOR CELL;

AUTOPHAGY; CELL COMMUNICATION; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MICROTUBULE-ASSOCIATED PROTEINS; PANCREATIC NEOPLASMS; RNA-BINDING PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 84861865743     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3396     Document Type: Article

References (50)

1. Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004;4:641-8. (Pubitemid 39025049)
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45. (Pubitemid 32173595)
4. Lotze MT, Deisseroth A, Rubartelli A. Damage associated molecular pattern molecules. Clin Immunol 2007;124:1-4. (Pubitemid 46936248)
5. Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2007;28:429-36. (Pubitemid 47444554)
6. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-74. (Pubitemid 40563170)
7. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress- inducibleMICA. Science 1999;285:727-9.
8. Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, et al. Human tumour immune evasion via TGF-beta blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS One 2011;6:e22842.
9. Carlsten M, Norell H, Bryceson YT, Poschke I, Schedvins K, Ljunggren HG, et al. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J Immunol 2009;183:4921-30.
10. Agaiby AD, Dyson M. Immuno-inflammatory cell dynamics during cutaneous wound healing. J Anat 1999;195:531-42. (Pubitemid 30003792)
11. Viswanathan K, Dhabhar FS. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc Natl Acad Sci U S A 2005;102:5808-13. (Pubitemid 40559641)
12. Feng Y, Santoriello C, Mione M, Hurlstone A, Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 2010;8:e1000562.
13. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011;12:21-7.
14. Koyasu S, Moro K. Type 2 innate immune responses and the natural helper cell. Immunology 2011;132:475-81.
15. Hepworth MR, Grencis RK. Disruption of Th2 immunity results in a gender-specific expansion of IL-13 producing accessory NK cells during helminth infection. J Immunol 2009;183:3906-14.
16. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457:722-5.
17. Vivier E, Spits H, Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol 2009;9:229-34.
18. Perlmann P, Perlmann H, Muller-Eberhard HJ, Manni JA. Cytotoxic effects of leukocyres triggered by complement bound to target cells. Science 1969;163:937-9.
19. Kaliss N. Micromethod for assaying immune cytolysis by the release of 51Cr. Transplantation 1969;8:526-30.
20. Bol SJ, Rosdorff HJ, Ronteltap CP, Hennen LA. Cellular cytotoxicity assessed by the 51Cr release assay. Biological interpretation of mathematical parameters. J Immunol Methods 1986;90:15-23. (Pubitemid 16082063)
21. Ito N, DeMarco RA, Mailliard RB, Han J, Rabinowich H, Kalinski P, et al. Cytolytic cells induce HMGB1 release from melanoma cell lines. J Leukoc Biol 2007;81:75-83. (Pubitemid 46021255)
22. Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011;147:223-34.
23. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007;282:24131-45. (Pubitemid 47328003)
24. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010;9:3256-76.
25. Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 1981;41:4420-5. (Pubitemid 12201351)
26. Harris J. Autophagy and cytokines. Cytokine 2011;56:140-4.
27. Abeyweera TP, Merino E, Huse M. Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J Cell Biol 2011;192:675-90.
28. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009;10:480-7.
29. Yap GS, Ling Y, Zhao Y. Autophagic elimination of intracellular parasites: convergent induction by IFN-gamma and CD40 ligation? Autophagy 2007;3:163-5. (Pubitemid 46449113)
30. Khalkhali-Ellis Z, Abbott DE, Bailey CM, Goossens W, Margaryan NV, Gluck SL, et al. IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells. J Cell Biochem 2008;105:208-18.
31. Hellstrom I. A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cells in vitro. Int J Cancer 1967;2:65-8.
32. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011;17:654-66.
33. Bauer PO, Goswami A, Wong HK, Okuno M, Kurosawa M, Yamada M, et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat Biotechnol 2010;28:256-63.
34. Tang D, Kang R, Xiao W, Zhang H, Lotze MT, Wang H, et al. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am J Respir Cell Mol Biol 2009;41:651-60.
35. Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 2010;70:288-98.
36. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009;137:1062-75.
37. Livesey KM, Tang D, Zeh HJ, Lotze MT. Not just nuclear proteins: 'novel' autophagy cancer treatment targets - p53 and HMGB1. Curr Opin Investig Drugs 2008;9:1259-63.
38. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011;25:717-29.
39. Chavez AR, Buchser W, Basse PH, Liang X, Appleman LJ, Maranchie JK, et al. Pharmacologic administration of interleukin-2. Ann N Y Acad Sci 2009;1182:14-27.
40. Lotze MT. Interleukin therapy. In:Vincent T, DeVita SH, Rosenberg SA, editors. Cancer: principles and practice of oncology. 9th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. p. 469-81.
41. Liang X, de Vera ME, Buchser WJ, Romo de Vivar Chavez A, Loughran P, Beer-Stolz D, et al. Inhibiting autophagy during interleukin 2 immunotherapy promotes long term tumor regression. Cancer Res. 2012 Apr 3. [Epub ahead of print].
42. Loux TJ, Lotze MT, Zeh HJ. NKcells as recipients of cytokine signals. In: Lotze MT, Thomson AW, editors. Natural killer cells basic science and clinical application. London, UK: Academic Press; 2010. p. 189-201.
43. Tu S, Quante M, Bhagat G, Takaishi S, Cui G, Yang XD, et al. Interferon-gamma inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T cell apoptosis. Cancer Res 2011;71:4247-59.
44. Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-speci fic CD8+ T cells. Cell Death Differ 2009;16:991-1005.
45. Virgin HW, Levine B. Autophagy genes in immunity. Nat Immunol 2009;10:461-70.
46. Ponpuak M, Davis AS, Roberts EA, Delgado MA, Dinkins C, Zhao Z, et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010;32:329-41.
47. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997;71:3236-43. (Pubitemid 27119971)
48. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002;169:5188-95. (Pubitemid 35217189)
49. Chijioke O, Munz C. Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol 2011;2011:251679.
50. Conigliaro P, Scrivo R, Valesini G, Perricone R. Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. Autoimmun Rev 2011;10:577-81.